Head of Scientific Advisory Board — Rachel W. Humphrey, M.D
1. Oncology
Glioblastoma (GBM)
Deborah Blumenthal, MD, Tel Aviv Sourasky Medical Center
Andrew J. Brenner, MD, PhD, The University of Texas Health Science Center
Nicholas Butowski, MD, University of California
Timothy Cloughesy, MD, UCLA
Patrick Y. Wen, MD, Dana-Farber Cancer Institute
Deborah Blumenthal, MD, Tel Aviv Sourasky Medical Center
Andrew J. Brenner, MD, PhD, The University of Texas Health Science Center
Nicholas Butowski, MD, University of California
Timothy Cloughesy, MD, UCLA
Patrick Y. Wen, MD, Dana-Farber Cancer Institute
Ovarian Cancer
Rebecca C. Arend, MD, University of Alabama at Birmingham
Robert A. Burger, MD, University of Pennsylvania
Thomas Herzog, MD, University of Cincinnati Cancer Institute
Bradley J. Monk, MD, FACS, FACOG, Univ. of Arizona& Creighton Univ.
Kathleen Moore, MD, University of Oklahoma Health Sciences Center
Richard T. Penson, MD, MRCP, Massachusetts General Hospital
Thyroid Cancer
Keith Bible, MD, PhD, Mayo Clinic Cancer Center
2. Additional Experts
Ronald Goldblum, MD, Carlsbad Pharmaceutical Consulting, Inc.
Bonnie Goldman, MD, Goldman Consulting, LLC
John Konz, PhD, Independent Consultant
Bonnie Goldman, MD, Goldman Consulting, LLC
John Konz, PhD, Independent Consultant
